Heparanase-2's Role in Cervical Cancer
Author Information
Author(s): Soboh Soaad, Vorontsova Avital, Farhoud Malik, Barash Uri, Naroditsky Inna, Gross-Cohen Miriam, Weissmann Marina, Nishioka Yasuhiko, Woolf Adrian S., Roberts Neil A., Shaked Yuval, Ilan Neta, Vlodavsky Israel
Primary Institution: Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel
Hypothesis
Heparanase-2 (Hpa2) functions as a tumor suppressor in cervical carcinoma.
Conclusion
High levels of Hpa2 are associated with prolonged survival in cervical cancer patients and reduced tumor growth.
Supporting Evidence
- High levels of Hpa2 correlate with prolonged survival of cervical carcinoma patients.
- Overexpression of Hpa2 in cervical carcinoma cells resulted in smaller tumor xenografts.
- Hpa2 staining intensity correlates with lower tumor grade.
- Hpa2 plays a critical role in macrophage polarization.
- Macrophages lacking Hpa2 shift towards a pro-tumorigenic M2 phenotype.
Takeaway
Hpa2 helps keep cancer cells from growing too much, and having more of it can help patients live longer.
Methodology
The study used a tissue microarray of cervical carcinoma biopsies and conditional knockout mice to assess the role of Hpa2.
Potential Biases
Potential bias in scoring Hpa2 staining intensity by a single pathologist.
Limitations
The study primarily focuses on cervical carcinoma and may not generalize to other cancer types.
Participant Demographics
Cervical carcinoma patients, specific demographics not detailed.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website